Riddhi Siddhi Gluco Biols Ltd

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 10 March 2026, providing investors with the latest insights into its performance and prospects.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 February 2026, providing investors with the latest insights into its performance and outlook.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 16 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Riddhi Siddhi Gluco Biols Ltd., a micro-cap trading and distribution company with a market capitalisation of ₹377.00 crores, reported deeply concerning Q3 FY26 results that highlight persistent operational challenges. The company posted a consolidated net loss of ₹1.59 crores for the quarter ended December 2025, representing a sharp 111.74% decline quarter-on-quarter and a 95.59% plunge year-on-year. The stock, trading at ₹530.00 as of February 06, 2026, has declined 8.67% over the past year, significantly underperforming the Sensex's 7.07% gain during the same period.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 February 2026, providing investors with the latest comprehensive view of the company’s position.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the most recent insights into its performance and outlook.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 January 2026, providing investors with the latest insights into its performance and outlook.

Riddhi Siddhi Gluco Biols Ltd’s stock declined to a fresh 52-week low of Rs.405 today, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.

Riddhi Siddhi Gluco Biols Ltd’s stock touched a fresh 52-week low of Rs.433.25 today, marking a significant downturn as the share price continues to slide amid persistent negative financial trends and underperformance relative to the broader market and sector indices.

Riddhi Siddhi Gluco Biols Ltd’s shares declined to a fresh 52-week low of Rs.441.2 on 29 Dec 2025, marking a significant downturn amid a series of quarterly setbacks and subdued financial metrics. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Trading & Distributors industry.

Riddhi Siddhi Gl, a microcap player in the Trading & Distributors sector, has experienced a notable revision in its market evaluation metrics, reflecting ongoing challenges in its financial and operational performance. This shift highlights the company’s current standing amid a difficult market environment and persistent negative trends across key financial parameters.

Riddhi Siddhi Gluco Biols touched a fresh 52-week low of Rs.448 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Trading & Distributors sector.

Riddhi Siddhi Gluco Biols touched a fresh 52-week low of Rs.451.2 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market valuation.